Large-scale testing (Phase 3)WithdrawnNCT07020832
What this trial is testing
Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
Who this might be right for
Delayed Graft FunctionEnd Stage Renal DiseaseDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.